Display options
Share it on

Iran J Microbiol. 2021 Jun;13(3):345-351. doi: 10.18502/ijm.v13i3.6397.

Curcumin-meropenem synergy in carbapenem resistant .

Iranian journal of microbiology

Dumrul Gülen, Birol Şafak, Berna Erdal, Betül Günaydın

Affiliations

  1. Department of Medical Microbiology, Tekirda? Nam?k Kemal University, Faculty of Medicine, Tekirda?, Turkey.

PMID: 34540173 PMCID: PMC8416589 DOI: 10.18502/ijm.v13i3.6397

Abstract

BACKGROUND AND OBJECTIVES: The frequency of multiple resistant bacterial infections, including carbapenems, is increasing worldwide. As the decrease in treatment options causes difficulties in treatment, interest in new antimicrobials is increasing. One of the promising natural ingredients is curcumin. It is known to be effective in bacteria such as

MATERIALS AND METHODS: Thirty-nine

RESULTS: Synergistic effects were observed in 4 isolates producing MBL, 3 isolates producing KPC, 4 isolates producing OXA-48, and 1 isolates producing AmpC (totally 12 isolates) according to the calculated FICI. No antagonistic effects were observed in any isolates.

CONCLUSION: Curcumin was thought to be an alternative antimicrobial in combination therapies that would positively contribute to the treatment of bacterial infection. The effectiveness of this combination should be confirmed by other

Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences.

Keywords: Anti-bacterial agents; Carbapenemase; Curcumin; Drug synergism; Klebsiella pneumoniae

References

  1. Mikrobiyol Bul. 2016 Jan;50(1):21-33 - PubMed
  2. Front Microbiol. 2019 Aug 20;10:1823 - PubMed
  3. J Microbiol Immunol Infect. 2017 Oct;50(5):653-661 - PubMed
  4. Clin Microbiol Infect. 2014 Sep;20(9):862-72 - PubMed
  5. Biochem Biophys Res Commun. 2005 Jan 14;326(2):472-4 - PubMed
  6. Antimicrob Agents Chemother. 2006 May;50(5):1859-60 - PubMed
  7. Biomed Res Int. 2014;2014:186864 - PubMed
  8. J Korean Med Sci. 2018 Sep 03;33(40):e255 - PubMed
  9. Lett Appl Microbiol. 2020 Jan;70(1):42-47 - PubMed
  10. J Antimicrob Chemother. 2009 Feb;63(2):337-9 - PubMed
  11. Phytomedicine. 2013 Jun 15;20(8-9):714-8 - PubMed
  12. Emerg Infect Dis. 2011 Oct;17(10):1791-8 - PubMed
  13. Toxicol Ind Health. 2016 Feb;32(2):246-50 - PubMed
  14. J Antimicrob Chemother. 2013 Jan;68(1):139-52 - PubMed
  15. Nutrients. 2021 Apr 30;13(5): - PubMed
  16. Euro Surveill. 2015;20(45): - PubMed
  17. Antibiotics (Basel). 2019 Aug 19;8(3): - PubMed
  18. Mem Inst Oswaldo Cruz. 2001 Jul;96(5):723-8 - PubMed
  19. J Clin Microbiol. 2014 Dec;52(12):4124-8 - PubMed
  20. Phytomedicine. 2008 Aug;15(8):639-52 - PubMed
  21. Curr Infect Dis Rep. 2018 Jun 29;20(9):29 - PubMed
  22. Biochem J. 2008 Feb 15;410(1):147-55 - PubMed
  23. J Chemother. 2015 Oct;27(5):277-82 - PubMed
  24. Front Cell Infect Microbiol. 2019 Sep 25;9:334 - PubMed
  25. J Agric Food Chem. 2008 Mar 26;56(6):1955-62 - PubMed
  26. Phytomedicine. 2017 Dec 15;37:27-48 - PubMed
  27. J Clin Diagn Res. 2014 Oct;8(10):DC04-7 - PubMed
  28. J Chemother. 2016 Aug;28(4):297-303 - PubMed
  29. J Basic Clin Pharm. 2016 Jun;7(3):93-6 - PubMed
  30. Front Microbiol. 2015 Apr 10;6:290 - PubMed
  31. Biochem Pharmacol. 2008 Feb 15;75(4):787-809 - PubMed

Publication Types